Literature DB >> 19625649

NK cells interfere with the generation of resistance against mycoplasma respiratory infection following nasal-pulmonary immunization.

Sheetal Bodhankar1, Mathew D Woolard, Xiangle Sun, Jerry W Simecka.   

Abstract

The purpose of the present study was to determine the impact of NK cells on the development of protective adaptive immunity in response to nasal-pulmonary immunization against mycoplasma. Depletion of NK cells before nasal-pulmonary immunization enhanced resistance to mycoplasma respiratory infection. The effect of NK cells on the generation of protective immunity in lungs was dependent on lymphoid cells, as immunization of either SCID mice or immunocompetent mice depleted of CD4(+) T cells did not demonstrate any increased resistance in the presence or absence of NK cells. The presence of NK cells at the time of nasal-pulmonary immunization modulated mycoplasma-specific cytokine responses in lungs and lower respiratory nodes. In particular, NK cells skewed the mycoplasma-specific T cell cytokine responses in the draining lymph nodes to higher IL-4, IL-13, and IL-17 while lowering IFN-gamma responses. Adoptive transfer of total lung lymphocytes isolated from immunized mice into naive mice led to a significant reduction in the mycoplasma numbers in lungs, and the resistance was greater if cells were obtained from immunized mice that were depleted of NK cells. Similar results were obtained if purified B cells, T cells, or CD4(+) T cells were used. Interestingly, this is the first time that a favorable role of functional CD4(+) T cells in mediating protection in mycoplasma respiratory disease was demonstrated. Thus, NK cells can influence the responses of multiple lymphocyte populations capable of mediating resistance to mycoplasma infection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19625649      PMCID: PMC2811958          DOI: 10.4049/jimmunol.0802180

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

1.  NK cells promote islet allograft tolerance via a perforin-dependent mechanism.

Authors:  Joshua N Beilke; Nathan R Kuhl; Luc Van Kaer; Ronald G Gill
Journal:  Nat Med       Date:  2005-09-11       Impact factor: 53.440

Review 2.  NK cell regulation of T cell-mediated responses.

Authors:  Alessandra Zingoni; Thierry Sornasse; Benjamin G Cocks; Yuetsu Tanaka; Angela Santoni; Lewis L Lanier
Journal:  Mol Immunol       Date:  2005-02       Impact factor: 4.407

3.  Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.

Authors:  Bibiana Bielekova; Marta Catalfamo; Susan Reichert-Scrivner; Amy Packer; Magdalena Cerna; Thomas A Waldmann; Henry McFarland; Pierre A Henkart; Roland Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

Review 4.  Natural killer cell-dendritic cell crosstalk in the initiation of immune responses.

Authors:  Thierry Walzer; Marc Dalod; Eric Vivier; Laurence Zitvogel
Journal:  Expert Opin Biol Ther       Date:  2005-09       Impact factor: 4.388

5.  NK cells in gamma-interferon-deficient mice suppress lung innate immunity against Mycoplasma spp.

Authors:  Matthew D Woolard; Dorothy Hudig; Leslie Tabor; James A Ivey; Jerry W Simecka
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

Review 6.  Natural killer cells in antiviral defense: function and regulation by innate cytokines.

Authors:  C A Biron; K B Nguyen; G C Pien; L P Cousens; T P Salazar-Mather
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

7.  NK cell-deficient mice develop a Th1-like response but fail to mount an efficient antigen-specific IgG2a antibody response.

Authors:  A R Satoskar; L M Stamm; X Zhang; M Okano; J R David; C Terhorst; B Wang
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

8.  Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice.

Authors:  Jean M Daley; Alan A Thomay; Michael D Connolly; Jonathan S Reichner; Jorge E Albina
Journal:  J Leukoc Biol       Date:  2007-09-20       Impact factor: 4.962

9.  F4/80+ alternatively activated macrophages control CD4+ T cell hyporesponsiveness at sites peripheral to filarial infection.

Authors:  Matthew D Taylor; Anjanette Harris; Meera G Nair; Rick M Maizels; Judith E Allen
Journal:  J Immunol       Date:  2006-06-01       Impact factor: 5.422

10.  Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children.

Authors:  F Freymuth; A Vabret; J Brouard; F Toutain; R Verdon; J Petitjean; S Gouarin; J F Duhamel; B Guillois
Journal:  J Clin Virol       Date:  1999-08       Impact factor: 3.168

View more
  8 in total

1.  Interferon gamma and interleukin 4 have contrasting effects on immunopathology and the development of protective adaptive immunity against mycoplasma respiratory disease.

Authors:  Sheetal Bodhankar; Xiangle Sun; Matthew D Woolard; Jerry W Simecka
Journal:  J Infect Dis       Date:  2010-07-01       Impact factor: 5.226

2.  Interleukin-17A Exacerbates Disease Severity in BALB/c Mice Susceptible to Lung Infection with Mycoplasma pulmonis.

Authors:  Maximillion T Mize; Xiangle L Sun; Jerry W Simecka
Journal:  Infect Immun       Date:  2018-08-22       Impact factor: 3.441

3.  Neutrophils are essential for induction of vaccine-like effects by antiviral monoclonal antibody immunotherapies.

Authors:  Mar Naranjo-Gomez; Jennifer Lambour; Marc Piechaczyk; Mireia Pelegrin
Journal:  JCI Insight       Date:  2018-05-03

4.  Regulatory CD4+CD25+ T Cells Dampen Inflammatory Disease in Murine Mycoplasma Pneumonia and Promote IL-17 and IFN-γ Responses.

Authors:  Adam N Odeh; Jerry W Simecka
Journal:  PLoS One       Date:  2016-05-13       Impact factor: 3.240

5.  Identifying genome-wide immune gene variation underlying infectious disease in wildlife populations - a next generation sequencing approach in the gopher tortoise.

Authors:  Jean P Elbers; Mary B Brown; Sabrina S Taylor
Journal:  BMC Genomics       Date:  2018-01-19       Impact factor: 3.969

6.  Nonspecific immunomodulators for recurrent respiratory tract infections, wheezing and asthma in children: a systematic review of mechanistic and clinical evidence.

Authors:  Susanna Esposito; Manuel E Soto-Martinez; Wojciech Feleszko; Marcus H Jones; Kun-Ling Shen; Urs B Schaad
Journal:  Curr Opin Allergy Clin Immunol       Date:  2018-06

7.  Immunomodulatory Role of NK Cells during Antiviral Antibody Therapy.

Authors:  Mar Naranjo-Gomez; Marine Cahen; Jennifer Lambour; Myriam Boyer-Clavel; Mireia Pelegrin
Journal:  Vaccines (Basel)       Date:  2021-02-08

Review 8.  Airway Natural Killer Cells and Bacteria in Health and Disease.

Authors:  Maud Theresine; Neha D Patil; Jacques Zimmer
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.